Dr. Julie Collins

Infectious Disease
Office
500 Grove St Ste 200, 
Haddon Heights, NJ 
Office
500 Grove St Ste 200, 
Haddon Heights, NJ 

Overview

Julie Collins is an Infectious Disease provider practicing medicine in Haddon Heights, New Jersey.

Her clinical expertise encompasses HER2 Negative Breast Cancer and BRCA Positive Breast Cancer.

She is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 2 clinical trials.

Specialties

Infectious Disease

Licenses

Internal Medicine in NJ

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
500 Grove St Ste 200, Haddon Heights, NJ 08035

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

TALAVE: A Pilot Trial of Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
TALAVE: A Pilot Trial of Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 09, 2026
Intervention Type: Drug
Study Drugs: Talazoparib, Avelumab
Study Phase: Phase 1/Phase 2
OASIS: Phase II Trial of OrAl SM-88 in Patients With Metastatic Hormone Receptor-posItive HER2-negative (HR+/HER2-) breaSt Cancer
OASIS: Phase II Trial of OrAl SM-88 in Patients With Metastatic Hormone Receptor-posItive HER2-negative (HR+/HER2-) breaSt Cancer
Enrollment Status: Terminated
Publish Date: August 28, 2023
Intervention Type: Drug
Study Drug: SM-88
Study Phase: Phase 2
View 1 Less Clinical Trial

12 Total Publications

Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort.
Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort.
Journal: Nature communications
Published: July 12, 2024
Similar Doctors
Expertise in
19
conditions
Dr. Emily A. Blumberg
Infectious Disease
Expertise in
19
conditions
Dr. Emily A. Blumberg
Infectious Disease

MacGregor Infection Medicine And Travel Program

3400 Civic Center Boulevard, South Pavilion, 4th Floor, 
Philadelphia, PA 
 (8.4 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Emily Blumberg is an Infectious Disease provider practicing medicine in Philadelphia, Pennsylvania. Dr. Blumberg is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Cytomegalovirus Infection, Cytomegalic Inclusion Disease, HIV/AIDS, Kidney Transplant, and Liver Transplant. Dr. Blumberg is board certified in Internal Medicine, 1984. Dr. Blumberg is currently accepting new patients.

Expertise in
13
conditions
Dr. Pablo Tebas
Infectious Disease
Expertise in
13
conditions
Dr. Pablo Tebas
Infectious Disease

MacGregor Infection Medicine And Travel Program

3400 Civic Center Boulevard, South Pavilion, 4th Floor, 
Philadelphia, PA 
 (8.4 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Pablo Tebas is an Infectious Disease provider practicing medicine in Philadelphia, Pennsylvania. Dr. Tebas is highly rated in 13 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Nontuberculous Mycobacterial Lung Disease, Myelitis, and AIDS Dysmorphic Syndrome. Dr. Tebas is board certified in Infectious Disease, 2005 and Internal Medicine, 2004. Dr. Tebas is currently accepting new patients.

Expertise in
7
conditions
Dr. Michael Z. David
Infectious Disease
Expertise in
7
conditions
Dr. Michael Z. David
Infectious Disease

MacGregor Infection Medicine And Travel Program

3400 Civic Center Boulevard, South Pavilion, 4th Floor, 
Philadelphia, PA 
 (8.4 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael David is an Infectious Disease provider practicing medicine in Philadelphia, Pennsylvania. Dr. David is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Osteomyelitis, Osteotomy, and Aneurysm Repair. Dr. David is board certified in Infectious Disease, 2009 and Internal Medicine, 2004. Dr. David is currently accepting new patients.

Frequently Asked Questions about Dr. Julie Collins

How do I make an appointment with Dr. Julie Collins?

You can book an appointment with Dr. Julie Collins by calling their office at 856-795-7505. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Julie Collins a top-rated expert for HER2 Negative Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Julie Collins is classified as an Experienced expert for HER2 Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Julie Collins specialize in?

While Dr. Julie Collins is a Infectious Disease, they have specific expertise in HER2 Negative Breast Cancer, BRCA Positive Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Julie Collins participate in research or clinical trials?

Yes. Dr. Julie Collins has published 12 articles and abstracts on conditions like HER2 Negative Breast Cancer. You can view a list of Dr. Julie Collins's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Collins's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile